Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price Aug 31, 2017
Interpace Diagnostics Group Reports Second Quarter 2017 Financial Results, Business Progress and Recent Accomplishments Aug 10, 2017
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Thursday August 10, 2017 Aug 9, 2017
Interpace Diagnostics Joins the Fight Against Pancreatic Cancer at the Pittsburgh PurpleStride Event Jul 13, 2017
